GILEAD SCIENCES, INC. Foreign Earnings Repatriated
GILEAD SCIENCES, INC. (GILD) reported Foreign Earnings Repatriated of $30.40 billion for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Notes › Income Taxes
us-gaap:ForeignEarningsRepatriated · last filed 2019-02-26
- GILEAD SCIENCES, INC. foreign earnings repatriated for the quarter ending 2018-12-31 was $700.00M.
- GILEAD SCIENCES, INC. foreign earnings repatriated for the quarter ending 2018-09-30 was $500.00M.
- GILEAD SCIENCES, INC. foreign earnings repatriated for the quarter ending 2018-06-30 was $1.20B.
- GILEAD SCIENCES, INC. foreign earnings repatriated for the quarter ending 2018-03-31 was $28.00B.
- GILEAD SCIENCES, INC. foreign earnings repatriated for fiscal 2018 was $30.40B.
| Period end | Foreign Earnings Repatriated 1 month | Foreign Earnings Repatriated 3 month | Foreign Earnings Repatriated 6 month | Foreign Earnings Repatriated 9 month | Foreign Earnings Repatriated 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $700.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.20B derived: sum of 2 quarters · filed 2019-02-26 | $2.40B derived: sum of 3 quarters · filed 2019-02-26 | $30.40B 10-K · filed 2019-02-26 | |
| 2018-09-30 | $500.00M 10-Q · filed 2018-11-06 | $1.70B derived: sum of 2 quarters · filed 2018-11-06 | $29.70B 10-Q · filed 2018-11-06 | ||
| 2018-06-30 | $1.20B 10-Q · filed 2018-08-06 | $29.20B 10-Q · filed 2018-08-06 | |||
| 2018-03-31 | $28.00B derived: 10-K 12 month − 3 quarters · filed 2019-02-26 | ||||
| 2018-02-28 | $28.00B 10-Q · filed 2018-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |